RecordLens
Menu

Claim review. Product claims

Unresolved

The available records do not permit a responsible conclusion.

Johnson & Johnson said in July 2026 that studies show talc does not cause cancer.

Studies show talc is safe, does not contain asbestos and does not cause cancer.
About
Johnson & Johnson
Claim made by
Johnson & Johnson, company statement
Published
27 July 2026
Original
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
Evidence score
48 How it was scored
Last reviewed
25 October 2026

Why this label

J&J has made the same claim since at least 2018S1S5. The question is being tested in court. J&J says a federal MDL order of 22 July 2026 required plaintiffs to show why remaining claims should not be dismissed for failure to prove specific causationS5. That order was not read here, and its outcome is pending. J&J has proposed to pay US$5.5 billion to resolve about 76,000 ovarian claims and says it has settled about 95% of filed mesothelioma suitsS5. Settlements do not decide causation either way. The asbestos part of the statement conflicts with the 2019 FDA test resultS2. The records read do not permit a responsible conclusion on whether J&J talc causes cancer.

Current procedural position

Company statement of 27 July 2026. Proposed resolution subject to 95% participation and other criteria. MDL specific causation order of 22 July 2026 pending as described by J&JS5.

Record supporting the assessment

Studies show talc is safe, does not contain asbestos and does not cause cancer.
S5 Tier B Johnson & Johnson, Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation, 27 July 2026
Studies of more than 100,000 men and women show that talc does not cause cancer or asbestos-related disease.
S1 Tier B Johnson & Johnson, Statement on Reuters Talc Article, 14 December 2018

Conflicting or limiting record

sub-trace levels of chrysotile asbestos contamination (no greater than 0.00002%)
S2 Tier B US Food and Drug Administration (company announcement), Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby Powder in the United States, 18 October 2019

Evidence score: 48 of 100

The score grades how well the record establishes this assessment. It is not a score of Johnson & Johnson. Score = source authority + directness + corroboration + procedural accuracy + currency + reproducibility.

ComponentPointsMaxReason
Source authorityIs the source competent to establish the proposition?1230The claim and the litigation status come mostly from company statements.
DirectnessDoes the source state the proposition or only discuss adjacent facts?1220The statements address causation directly but are not independent evidence.
CorroborationDo independent records support the same material point?415No independent scientific or court record on causation was read.
Procedural accuracyDoes the record settle the procedural state the claim describes?315Causation questions remain open in the MDL and the settlement is not final.
CurrencyHas the record been checked against later developments?910Checked against the 27 July 2026 release.
ReproducibilityCan a reader locate the passage and repeat the assessment?810The releases are public. The MDL order was not read.
Total48100

Timeline

  1. J&J says talc does not cause cancerS1
  2. MDL order on specific causation, as described by J&JS5
  3. J&J announces proposed US$5.5 billion ovarian talc resolutionS5

Revision history

  • Assessment first published with label Unresolved.

Have a record that changes this assessment? See corrections and responses.

Sources

  1. S5Tier B Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc LitigationJohnson & Johnson. Company statement. 27 July 2026.Announces a proposed US$5.5 billion resolution and repeats J&J's safety position. It describes the MDL order but is not a court record.Link working, checked 25 October 2026
  2. S1Tier B Statement on Reuters Talc ArticleJohnson & Johnson. Company statement. 14 December 2018.J&J's rebuttal of the Reuters report. It is the company's position, not a finding.Link working, checked 25 October 2026
  3. S2Tier B Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby Powder in the United StatesUS Food and Drug Administration (company announcement). Company statement. 18 October 2019.Company recall notice posted by FDA, reporting the FDA test result for one lot. FDA says it posts such notices as a public service and does not endorse the company.Link working, checked 25 October 2026

Other claims about Johnson & Johnson